Dose justification for [fam-] trastuzumab deruxtecan (DS-8201a) in HER2-positive breast cancer

Shunji Takahashi; Shanu Modi; Junji Tsurutani; Ian E. Krop; Hiroji Iwata; Russell Wada; Ophelia Yin; Τushar Garimella; Masahiro Sugihara; Lin Zhang

doi:10.1093/annonc/mdz339.009

Dose justification for [fam-] trastuzumab deruxtecan (DS-8201a) in HER2-positive breast cancer

NobleID: NI2P08W02R21S75
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/63ECBFCB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/63ECBFCB.svg?ark=w1%2F20260515%2F63ECBFCB&value=id)](https://nobleid.org/work/w1/20260515/63ECBFCB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Dose justification for [fam-] trastuzumab deruxtecan (DS-8201a) in HER2-positive breast cancer

NobleID: NI2P08W02R21S75
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/63ECBFCB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/63ECBFCB.svg?ark=w1%2F20260515%2F63ECBFCB&value=id)](https://nobleid.org/work/w1/20260515/63ECBFCB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work